← All Representatives

Filemon Vela

House of Representatives · TX · former Representative

Terms: from 3 January 2013 to 11 December 2014 ; from 6 January 2015 to 8 December 2016 ; from 3 January 2017 to 21 December 2018 ; from 3 January 2019 to 28 December 2020 ; from 3 January 2021 to 31 March 2022

Participation in roll-call votes

96 % of the 5,229 roll-call votes held during their term: took part in the vote (for, against or abstention)

Participation month by month

0 % 50 % 100 % January 2013 : participation 100 % (28 / 28), presence 100 % (28 / 28) 2013 February 2013 : participation 100 % (25 / 25), presence 100 % (25 / 25) March 2013 : participation 97 % (33 / 34), presence 97 % (33 / 34) April 2013 : participation 100 % (39 / 39), presence 100 % (39 / 39) May 2013 : participation 100 % (55 / 55), presence 100 % (55 / 55) June 2013 : participation 99 % (120 / 121), presence 99 % (120 / 121) July 2013 : participation 99 % (122 / 123), presence 99 % (122 / 123) August 2013 : participation 100 % (20 / 20), presence 100 % (20 / 20) September 2013 : participation 96 % (55 / 57), presence 96 % (55 / 57) October 2013 : participation 98 % (65 / 66), presence 98 % (65 / 66) November 2013 : participation 100 % (41 / 41), presence 100 % (41 / 41) December 2013 : participation 90 % (27 / 30), presence 90 % (27 / 30) January 2014 : participation 100 % (30 / 30), presence 100 % (30 / 30) 2014 February 2014 : participation 98 % (58 / 59), presence 98 % (58 / 59) March 2014 : participation 98 % (57 / 58), presence 98 % (57 / 58) April 2014 : participation 100 % (39 / 39), presence 100 % (39 / 39) May 2014 : participation 81 % (68 / 84), presence 81 % (68 / 84) June 2014 : participation 99 % (96 / 97), presence 99 % (96 / 97) July 2014 : participation 97 % (102 / 105), presence 97 % (102 / 105) August 2014 : participation 100 % (7 / 7), presence 100 % (7 / 7) September 2014 : participation 100 % (35 / 35), presence 100 % (35 / 35) November 2014 : participation 100 % (16 / 16), presence 100 % (16 / 16) December 2014 : participation 100 % (33 / 33), presence 100 % (33 / 33) January 2015 : participation 100 % (48 / 48), presence 100 % (48 / 48) 2015 February 2015 : participation 98 % (55 / 56), presence 98 % (55 / 56) March 2015 : participation 97 % (37 / 38), presence 97 % (37 / 38) April 2015 : participation 100 % (63 / 63), presence 100 % (63 / 63) May 2015 : participation 100 % (56 / 56), presence 100 % (56 / 56) June 2015 : participation 96 % (121 / 126), presence 96 % (121 / 126) July 2015 : participation 99 % (99 / 100), presence 99 % (99 / 100) September 2015 : participation 100 % (39 / 39), presence 100 % (39 / 39) October 2015 : participation 96 % (49 / 51), presence 96 % (49 / 51) November 2015 : participation 100 % (64 / 64), presence 100 % (64 / 64) December 2015 : participation 100 % (60 / 60), presence 100 % (60 / 60) January 2016 : participation 98 % (43 / 44), presence 98 % (43 / 44) 2016 February 2016 : participation 93 % (53 / 57), presence 93 % (53 / 57) March 2016 : participation 94 % (34 / 36), presence 94 % (34 / 36) April 2016 : participation 98 % (40 / 41), presence 98 % (40 / 41) May 2016 : participation 98 % (87 / 89), presence 98 % (87 / 89) June 2016 : participation 95 % (70 / 74), presence 95 % (70 / 74) July 2016 : participation 99 % (134 / 136), presence 99 % (134 / 136) September 2016 : participation 98 % (94 / 96), presence 98 % (94 / 96) November 2016 : participation 89 % (17 / 19), presence 89 % (17 / 19) December 2016 : participation 72 % (21 / 29), presence 72 % (21 / 29) January 2017 : participation 100 % (67 / 67), presence 100 % (67 / 67) 2017 February 2017 : participation 100 % (39 / 39), presence 100 % (39 / 39) March 2017 : participation 98 % (98 / 100), presence 98 % (98 / 100) April 2017 : participation 100 % (28 / 28), presence 100 % (28 / 28) May 2017 : participation 100 % (49 / 49), presence 100 % (49 / 49) June 2017 : participation 97 % (57 / 59), presence 97 % (57 / 59) July 2017 : participation 100 % (94 / 94), presence 100 % (94 / 94) September 2017 : participation 98 % (103 / 105), presence 98 % (103 / 105) October 2017 : participation 100 % (48 / 48), presence 100 % (48 / 48) November 2017 : participation 100 % (58 / 58), presence 100 % (58 / 58) December 2017 : participation 97 % (59 / 61), presence 97 % (59 / 61) January 2018 : participation 81 % (39 / 48), presence 81 % (39 / 48) 2018 February 2018 : participation 100 % (41 / 41), presence 100 % (41 / 41) March 2018 : participation 89 % (34 / 38), presence 89 % (34 / 38) April 2018 : participation 97 % (36 / 37), presence 97 % (36 / 37) May 2018 : participation 100 % (64 / 64), presence 100 % (64 / 64) June 2018 : participation 84 % (70 / 83), presence 84 % (70 / 83) July 2018 : participation 97 % (64 / 66), presence 97 % (64 / 66) September 2018 : participation 97 % (35 / 36), presence 97 % (35 / 36) November 2018 : participation 90 % (9 / 10), presence 90 % (9 / 10) December 2018 : participation 57 % (43 / 75), presence 57 % (43 / 75) January 2019 : participation 100 % (63 / 63), presence 100 % (63 / 63) 2019 February 2019 : participation 100 % (38 / 38), presence 100 % (38 / 38) March 2019 : participation 100 % (33 / 33), presence 100 % (33 / 33) April 2019 : participation 100 % (35 / 35), presence 100 % (35 / 35) May 2019 : participation 97 % (58 / 60), presence 97 % (58 / 60) June 2019 : participation 99 % (198 / 199), presence 99 % (198 / 199) July 2019 : participation 99 % (83 / 84), presence 99 % (83 / 84) September 2019 : participation 100 % (41 / 41), presence 100 % (41 / 41) October 2019 : participation 98 % (53 / 54), presence 98 % (53 / 54) November 2019 : participation 97 % (32 / 33), presence 97 % (32 / 33) December 2019 : participation 100 % (59 / 59), presence 100 % (59 / 59) January 2020 : participation 97 % (32 / 33), presence 97 % (32 / 33) 2020 February 2020 : participation 98 % (43 / 44), presence 98 % (43 / 44) March 2020 : participation 92 % (22 / 24), presence 92 % (22 / 24) April 2020 : participation 100 % (2 / 2), presence 100 % (2 / 2) May 2020 : participation 100 % (11 / 11), presence 100 % (11 / 11) June 2020 : participation 94 % (17 / 18), presence 94 % (17 / 18) July 2020 : participation 100 % (45 / 45), presence 100 % (45 / 45) August 2020 : participation 100 % (4 / 4), presence 100 % (4 / 4) September 2020 : participation 100 % (31 / 31), presence 100 % (31 / 31) October 2020 : participation 100 % (5 / 5), presence 100 % (5 / 5) November 2020 : participation 100 % (9 / 9), presence 100 % (9 / 9) December 2020 : participation 92 % (24 / 26), presence 92 % (24 / 26) January 2021 : participation 100 % (16 / 16), presence 100 % (16 / 16) 2021 February 2021 : participation 97 % (30 / 31), presence 97 % (30 / 31) March 2021 : participation 94 % (45 / 48), presence 94 % (45 / 48) April 2021 : participation 97 % (35 / 36), presence 97 % (35 / 36) May 2021 : participation 96 % (22 / 23), presence 96 % (22 / 23) June 2021 : participation 100 % (48 / 48), presence 100 % (48 / 48) July 2021 : participation 98 % (49 / 50), presence 98 % (49 / 50) August 2021 : participation 67 % (4 / 6), presence 67 % (4 / 6) September 2021 : participation 96 % (50 / 52), presence 96 % (50 / 52) October 2021 : participation 96 % (26 / 27), presence 96 % (26 / 27) November 2021 : participation 69 % (34 / 49), presence 69 % (34 / 49) December 2021 : participation 97 % (59 / 61), presence 97 % (59 / 61) January 2022 : participation 100 % (13 / 13), presence 100 % (13 / 13) 2022 February 2022 : participation 97 % (33 / 34), presence 97 % (33 / 34) March 2022 : participation 93 % (50 / 54), presence 93 % (50 / 54)

Their votes

2,270 votes

DateTextResultTheir vote
H.R. 3233: National Commission to Investigate the January 6 Attack on the United States Capitol Complex Act ✓ Adopted For
H.Res. 409: Providing for consideration of the bill (H.R. 3233) National Commission to Investigate the January 6 Attack on the United States Capitol Complex Act; and providing for consideration of the bill (H.R. 3237) Emergency Security Supplemental to Respond to January 6th Appropriations Act, 2021, and for other purposes ✓ Adopted For
H.R. 1629: Fairness in Orphan Drug Exclusivity Act ✓ Adopted For
H.Res. 275: Condemning the horrific shootings in Atlanta, Georgia, on March 16, 2021, and reaffirming the House of Representative’s commitment to combating hate, bigotry, and violence against the Asian-American and Pacific Islander community ✓ Adopted For
MOTION — On Motion to Suspend the Rules and Pass Certain Bills ✓ Adopted For
H.Res. 403: Providing for consideration of H.R. 1629,the Fairness in Orphan Drug Exclusivity Act; and H. Res. 275, condemning the horrific shootings in Atlanta, GA on March 16, 2021 ✓ Adopted For
S. 937: COVID-19 Hate Crimes Act ✓ Adopted For
H.R. 2911: VA Transparency & Trust Act ✓ Adopted For
H.R. 1065: Pregnant Workers Fairness Act ✓ Adopted For
H.R. 2877: Behavioral Intervention Guidelines Act of 2021 ✓ Adopted Absent
H.R. 2547: Comprehensive Debt Collection Improvement Act ✓ Adopted For
MOTION — On Motion to Suspend the Rules and Pass Certain Bills ✓ Adopted For
H.Res. 380: Providing for consideration of the bill (H.R. 2547) Comprehensive Debt Collection Improvement Act; providing for consideration of the bill (H.R. 1065) Pregnant Workers Fairness Act and for other purposes ✓ Adopted For
H.R. 1629: Fairness in Orphan Drug Exclusivity Act ✗ Rejected For
H.R. 51: Washington, D.C. Admission Act ✓ Adopted For
H.R. 1392: Protection of Saudi Dissidents Act ✓ Adopted For
H.R. 1573: Access to Counsel Act ✓ Adopted For
H.R. 1333: NO BAN Act ✓ Adopted For
MOTION — On Motion to Suspend the Rules and Pass Certain Bills and Agree to a Resolution ✓ Adopted For
H.Res. 330: Providing for consideration of the bill (H.R. 51) Washington, D.C. Admission Act; providing for consideration of the bill (H.R. 1573) Access to Counsel Act; providing for consideration of the bill (H.R. 1333) NO BAN Act; and for other purposes ✓ Adopted For
H.Res. 130: Condemning the continued violation of rights and freedoms of the people of Hong Kong by the People’s Republic of China and the Government of the Hong Kong Special Administrative Region ✓ Adopted For
H.R. 1996: SAFE Banking Act ✓ Adopted For
H.R. 1482: 504 Credit Risk Management Improvement Act ✓ Adopted For
H.R. 1195: Workplace Violence Prevention for Health Care and Social Service Workers Act ✓ Adopted For
H.R. 1490: 504 Modernization and Small Manufacturer Enhancement Act ✓ Adopted Absent
H.R. 1487: Microloan Transparency and Accountability Act ✓ Adopted For
H.R. 1502: Microloan Improvement Act ✓ Adopted For
H.R. 1899: Ensuring Compliance Against Drug Diversion Act ✓ Adopted For
H.R. 1002: Debarment Enforcement of Bad Actor Registrants Act ✓ Adopted For
H.R. 1762: Protecting Indian Tribes from Scams Act ✓ Adopted For
H.R. 446: Protecting Seniors from Emergency Scams Act ✓ Adopted For
H.R. 941: TRANSPLANT Act ✓ Adopted For
H.R. 7: Paycheck Fairness Act ✓ Adopted For
H.R. 1460: Nicholas and Zachary Burt Memorial Carbon Monoxide Poisoning Prevention Act ✓ Adopted For
H.R. 1215: Fraud and Scam Reduction Act ✓ Adopted For
H.Res. 303: Providing for consideration of H.R. 7, the Paycheck Fairness Act and H.R. 1195, the Workplace Violence Prevention for Health Care and Social Service Workers Act ✓ Adopted For
S. 164: Advancing Education on Biosimilars Act ✓ Adopted For
S. 578: Food Allergy Safety, Treatment, Education, and Research Act ✓ Adopted For
H.R. 172: United States Anti-Doping Agency Reauthorization Act ✓ Adopted For
H.Res. 134: Condemning the military coup that took place on February 1, 2021, in Burma and the Burmese military detention of civilian leaders, calling for the release of all those detained and for those elected to serve Parliament to resume their duties, and for other purposes ✓ Adopted For

Rows per page: 20 40 100 200